Inventor · disambiguated record
Gnanasambandam Kumaravel
Also filed as: KUMARAVEL GNANASAMBANDAM
66 granted patents·25 pending applications·452 citations·filing 1992–2024
99Inventor score
Files withBIOGEN MA INC32BIOGEN IDEC INC8PADLOCK THERAPEUTICS INC7KINETA INC5SUNESIS PHARMACEUTICALS INC5
Top patents by PatentIndex Score
91 records- 0192US10166250B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Jan 1, 2019·9 cites·11 claims
- 0292US9790229B2Bruton's tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Granted Oct 17, 2017·11 cites·21 claims
- 0392US9572824B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2015·Granted Feb 21, 2017·10 cites·14 claims
- 0492US8802659B2Bicyclic aryl sphingosine 1-phosphate analogsTHOMAS JERMAINE·Filed 2010·Granted Aug 12, 2014·20 cites·24 claims
- 0591US10081619B2Biaryl inhibitors of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2017·Granted Sep 25, 2018·7 cites·4 claims
- 0691US9827258B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Nov 28, 2017·8 cites·10 claims
- 0791US9809577B2Biaryl inhibitors of Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2014·Granted Nov 7, 2017·12 cites·2 claims
- 0891US9186367B2Bicyclic aryl sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2014·Granted Nov 17, 2015·15 cites·14 claims
- 0991US8785440B2Bruton's tyrosine kinase inhibitorsBUI MINNA·Filed 2010·Granted Jul 22, 2014·20 cites·20 claims
- 1090US10759783B2Biaryl inhibitors of Bruton'S tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Sep 1, 2020·3 cites·11 claims
- 1189US9249146B2Bruton'S tyrosine kinase inhibitorsBIOGEN IDEC INC·Filed 2014·Granted Feb 2, 2016·9 cites·25 claims
- 1289US6207679B1Antimicrobial agents uses and compositions related theretoSEPRACOR INC·Filed 1998·Granted Mar 27, 2001·54 cites·182 claims
- 1388US9771326B2S1P and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Sep 26, 2017·6 cites·11 claims
- 1488US6649600B1Adenosine receptor antagonists and methods of making and using the sameBIOGEN INC·Filed 2000·Granted Nov 18, 2003·31 cites·38 claims
- 1588US6172084B1Quinoline-indole antimicrobial agents, uses and compositions related theretoSEPRACOR INC·Filed 1998·Granted Jan 9, 2001·50 cites·192 claims
- 1686US9550798B2Compounds that are S1P modulating agents and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Jan 24, 2017·8 cites·25 claims
- 1785US9555050B2ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Jan 31, 2017·4 cites·24 claims
- 1884US9850206B2S1P and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Dec 26, 2017·4 cites·22 claims
- 1984US9340527B2S1P modulating agentsTHOMAS JERMAINE·Filed 2012·Granted May 17, 2016·6 cites·38 claims
- 2084US9181191B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2012·Granted Nov 10, 2015·3 cites·38 claims
- 2184US9029359B2Heteroaryl Btk inhibitorsBUI MINNA·Filed 2010·Granted May 12, 2015·12 cites·18 claims
- 2284US7968536B2Heterocyclic compounds useful as RAF kinase inhibitorsMILLENNIUM PHARM INC·Filed 2008·Granted Jun 28, 2011·9 cites·31 claims
- 2384US6605600B1Adenosine receptor antagonists and methods of making and using the sameBIOGEN INC·Filed 2000·Granted Aug 12, 2003·18 cites·29 claims
- 2484US2024246988A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2584US2024294524A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2682US10577374B2Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2017·Granted Mar 3, 2020·2 cites·18 claims
- 2782US10246456B2IRAK4 inhibiting agentsBIOGEN MA INC·Filed 2015·Granted Apr 2, 2019·5 cites·4 claims
- 2882US9522889B2ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Dec 20, 2016·5 cites·31 claims
- 2982US8349849B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2009·Granted Jan 8, 2013·6 cites·21 claims
- 3081US10034869B2S1P modulating agentsBIOGEN MA INC·Filed 2017·Granted Jul 31, 2018·2 cites·18 claims
- 3181US8802657B2Compounds useful as Raf kinase inhibitorsMILLENNIUM PHARM INC·Filed 2012·Granted Aug 12, 2014·4 cites·19 claims
- 3280US10030016B2Heterocyclic compounds useful as PDK1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 24, 2018·2 cites·16 claims
- 3380US9808449B2S1P modulating agentsBIOGEN MA INC·Filed 2015·Granted Nov 7, 2017·2 cites·21 claims
- 3480US8293752B2Compounds useful as Raf kinase inhibitorsCHEN WEIRONG·Filed 2008·Granted Oct 23, 2012·6 cites·13 claims
- 3579US9499485B2Compounds that are S1P modulating agents and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Nov 22, 2016·4 cites·14 claims
- 3678US11198681B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Dec 14, 2021·4 cites·15 claims
- 3778US2023046457A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3877US8546359B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2012·Granted Oct 1, 2013·4 cites·31 claims
- 3977US7834014B2A2a adenosine receptor antagonistsBIOGEN IDEC INC·Filed 2004·Granted Nov 16, 2010·10 cites·27 claims
- 4077US5196418AHemicholinium lipids and use thereofSUPERVISORS LOUISIANA STATE UN·Filed 1992·Granted Mar 23, 1993·18 cites·12 claims
- 4177US2023113598A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4276US10894040B2S1P modulating agentsBIOGEN MA INC·Filed 2019·Granted Jan 19, 2021·0 cites·20 claims
- 4374US8269043B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2009·Granted Sep 18, 2012·2 cites·19 claims
- 4473US10577367B2IRAK4 inhibiting agentsBIOGEN MA INC·Filed 2019·Granted Mar 3, 2020·1 cites·6 claims
- 4573US7674791B2Triazolopyrazines and methods of making and using the sameBIOGEN IDEC INC·Filed 2004·Granted Mar 9, 2010·7 cites·13 claims
- 4673US6103905AQuinoline-indole antimicrobial agents, uses and compositions related theretoSEPRACOR INC·Filed 1998·Granted Aug 15, 2000·17 cites·31 claims
- 4771US11026937B2Heteroaryl inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2017·Granted Jun 8, 2021·1 cites·7 claims
- 4870US9963448B2Bicyclic inhibitors of PAD4PADLOCK THERAPEUTICS INC·Filed 2016·Granted May 8, 2018·2 cites·20 claims
- 4970US9546165B2Heterocyclic compounds useful as PDK1 inhibitorsARNDT JOSEPH·Filed 2010·Granted Jan 17, 2017·2 cites·12 claims
- 5070US2021070752A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 91 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →